Pharmaceutical - Mundipharma


Current filters:


Popular Filters

Exclusive: Changing pharma marketplace means new dynamics to deal with, says Mundipharma executive


The pharmaceutical market is changing, says Georg Toufar, chief marketing officer of Mundipharma International,…

InterviewsManagementMarkets & MarketingMundipharmaPharmaceutical

Skyepharma launches Flutiform in France for asthma


UK drug delivery specialist Skyepharma has received regulatory approval and agreement on pricing reimbursement…

FlutiformFranceMarkets & MarketingMundipharmaPharmaceuticalRespiratory and PulmonarySkyepharma

Mundipharma strengthens patent rights for heroin substitution in deal with Phoenux


Privately-held drugmaker Mundipharma International has acquired exclusive global rights to a family of…


Helsinn and Mundipharma collaborate on netupitant-palonosetron for China

Helsinn and Mundipharma collaborate on netupitant-palonosetron for China


Privately-held Swiss drugmakers Helsinn and Mundipharma have signed a new, exclusive license and distribution…


Horizon Pharma and Mundipharma in deal for Lodotra in Middle East and Africa


USA-based Horizon Pharma has signed an exclusive agreement with privately-held Swiss drugmaker Mundipharma…

Anti-Arthritics/RheumaticsHorizon PharmaLicensingLodotraMundipharmaPharmaceuticalRest of the World

Flutiform trial for COPD initiated in Europe

Flutiform trial for COPD initiated in Europe


UK drug delivery specialist Skyepharma (LSE: SKP) and privately-held Swiss drugmaker Mundipharma, which…

FlutiformMundipharmaPharmaceuticalResearchRespiratory and PulmonarySkyepharma

Mundipharma's bendamustine plus rituximab doubles PFS in non-Hodgkin lymphoma and MCL patients


Results from the StiL NHL-1 study published in the Lancet today (February 20) show that a first-line…

bendamustineLevactMundipharmaOncologyPharmaceuticalResearchTeva Pharmaceutical IndustriesTreanda

SkyePharma/Mundipharma's Flutiform launched in Germany


UK-based drug delivery specialist SkyePharma (LSE: SKP) last Friday announced the launch of Flutiform,…

EuropeFlutiformMarkets & MarketingMundipharmaPharmaceuticalRespiratory and PulmonarySkyepharma

EMA recommendations to deal with sterility concerns for DepoCyte


The European Medicines Agency last Friday agreed a number of precautionary measures to deal with manufacturing…

DepoCyteEuropeMundipharmaOncologyPacira PharmaceuticalsPharmaceuticalRegulationSigma Tau

Flutiform receives UK regulatory approval; solid financials from SkyePharma


UK-based drug delivery specialist SkyePharma (LSE: SKP) yesterday announced that the UK the Medicines…

FinancialFlutiformMundipharmaPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

Infinity regains global rights to PI3K, FAAH; equity investment by Purdue


USA-based Infinity Pharmaceuticals (Nasdaq: INFI) says it has restructured its strategic alliance with…

FinancialInfinity PharmaceuticalsLicensingMundipharmaPharmaceuticalPurdue PharmaResearch

European approval for Mundipharma/SkyePharma's asthma drug Flutiform


After some delays, the European Commission has now adopted a legally binding decision in favor of granting…

EuropeFlutiformMundipharmaPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

Infinity plunges as it halts two saridegib trials


US drug discovery firm Infinity Pharmaceuticals (Nasdaq: INFI) saw its shares plummet 20% to $11 in pre-marketing…

Infinity PharmaceuticalsIPI-145MundipharmaOncologyPharmaceuticalResearchretaspimycinsaridegib

Company Spotlight



Back to top